Tech Company Financing Transactions
Saguaro Biosciences Funding Round
On 6/4/2024, Saguaro Biosciences raised $3 million in Seed funding from Anges Quebec, AQC Capital and Investissement Quebec.
Transaction Overview
Company Name
Announced On
6/4/2024
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to drive the commercial expansion of ChromaLive�, its reagent platform, which enables time-sensitive imaging and AI-enabled analysis of cells.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Espace Entrepreneurial 2325 rue de l'Université 1250
Québec, QC, G1V 0A6
Canada
Québec, QC, G1V 0A6
Canada
Phone
Undisclosed
Website
Email Address
Overview
Saguaro builds next-generation cell culture products to improve drug discovery success. We start with the challenges of drug discovery in mind and focus on technologies that can generate step-function improvements to this risky endeavour.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Louis Turcotte
Co-Founder
Felix Lavoie-Perusse
Browse more venture capital transactions:
Prev: 6/4/2024: Spike Technologies venture capital transaction
Next: 6/4/2024: Storyblok venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs